Okezaki E - Search Results

1

Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes.

Tsuji A, Sato H, Kume Y, Tamai I, Okezaki E, Nagata O, Kato H. Tsuji A, et al. Among authors: okezaki e. Antimicrob Agents Chemother. 1988 Feb;32(2):190-4. doi: 10.1128/AAC.32.2.190. Antimicrob Agents Chemother. 1988. PMID: 2834994 Free PMC article.

2

Effect of the anti-inflammatory agent fenbufen on the quinolone-induced inhibition of gamma-aminobutyric acid binding to rat brain membranes in vitro.

Tsuji A, Sato H, Okezaki E, Nagata O, Kato H. Tsuji A, et al. Among authors: okezaki e. Biochem Pharmacol. 1988 Nov 15;37(22):4408-11. doi: 10.1016/0006-2952(88)90625-9. Biochem Pharmacol. 1988. PMID: 2848527 No abstract available.

3

Entry of the new quinolone antibacterial agents of ofloxacin and NY-198 into the central nervous system in rats.

Sato H, Okezaki E, Yamamoto S, Nagata O, Kato H, Tsuji A. Sato H, et al. Among authors: okezaki e. J Pharmacobiodyn. 1988 Jun;11(6):386-94. doi: 10.1248/bpb1978.11.386. J Pharmacobiodyn. 1988. PMID: 3171880

4

Enterohepatic circulation of NY-198, a new difluorinated quinolone, in rats.

Saito A, Nagata O, Takahara Y, Okezaki E, Yamada T, Ito Y. Saito A, et al. Among authors: okezaki e. Antimicrob Agents Chemother. 1988 Jan;32(1):156-7. doi: 10.1128/AAC.32.1.156. Antimicrob Agents Chemother. 1988. PMID: 3348607 Free PMC article.

5

Serum protein binding of lomefloxacin, a new antimicrobial agent, and its related quinolones.

Okezaki E, Terasaki T, Nakamura M, Nagata O, Kato H, Tsuji A. Okezaki E, et al. J Pharm Sci. 1989 Jun;78(6):504-7. doi: 10.1002/jps.2600780618. J Pharm Sci. 1989. PMID: 2760827

6

In vitro and in vivo activity of NY-198, a new difluorinated quinolone.

Hirose T, Okezaki E, Kato H, Ito Y, Inoue M, Mitsuhashi S. Hirose T, et al. Among authors: okezaki e. Antimicrob Agents Chemother. 1987 Jun;31(6):854-9. doi: 10.1128/AAC.31.6.854. Antimicrob Agents Chemother. 1987. PMID: 3476021 Free PMC article.

7

In-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, against clinical isolates of Neisseria gonorrhoeae with quinolone resistance-associated alterations in GyrA and ParC.

Deguchi T, Yasuda M, Ishihara S, Takahashi Y, Okezaki E, Nagata O, Saito I, Kawada Y. Deguchi T, et al. Among authors: okezaki e. J Antimicrob Chemother. 1997 Sep;40(3):437-9. doi: 10.1093/jac/40.3.437. J Antimicrob Chemother. 1997. PMID: 9338500

8

[Bactericidal action of lomefloxacin a new pyridonecarboxylic acid derivative].

Koikeda S, Okabe H, Shibata H, Hase T, Nakanishi N, Okezaki E, Kato H, Masamune Y. Koikeda S, et al. Among authors: okezaki e. Jpn J Antibiot. 1989 Jan;42(1):193-9. Jpn J Antibiot. 1989. PMID: 2468799 Japanese.

9

Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids.

Okezaki E, Terasaki T, Nakamura M, Nagata O, Kato H, Tsuji A. Okezaki E, et al. Drug Metab Dispos. 1988 Nov-Dec;16(6):865-74. Drug Metab Dispos. 1988. PMID: 2907467

10

In-vitro antimicrobial activity of HSR-903, a new fluoroquinolone, against clinical isolates of Klebsiella pneumoniae and Enterobacter cloacae with fluoroquinolone resistance-associated amino acid alterations in GyrA and ParC.

Deguchi T, Yasuda M, Kawamura T, Takahashi Y, Okezaki E, Nagata O, Kato H, Kawada Y. Deguchi T, et al. Among authors: okezaki e. J Antimicrob Chemother. 1997 Dec;40(6):907-9. doi: 10.1093/jac/40.6.907. J Antimicrob Chemother. 1997. PMID: 9462448 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters